The relationship between Epstein-Barr virus and lymphoma.
D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology / Q000382:microbiology; D002051:Burkitt Lymphoma / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D002648:Child; D005260:Female; D005819:Genetic Markers; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000382:microbiology; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007244:Infectious Mononucleosis / Q000276:immunology / Q000382:microbiology; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000276:immunology / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous / Q000009:adverse effects
D000914:Antibodies, Viral; D005819:Genetic Markers